OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

Summary aggregated from TechCrunch's public RSS feed. The full reporting belongs to TechCrunch — please read it on their site.